Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,322 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Relationships between quantitative electroencephalographic alterations and the severity of hepatitis C based on liver biopsy in interferon-alpha treated patients.
Kamei S, Morita A, Tanaka N, Matsuura M, Moriyama M, Kojima T, Arakawa Y, Matsukawa Y, Mizutani T, Sakai T, Oga K, Ohkubo H, Matsumura H, Hirayanagi K. Kamei S, et al. Among authors: arakawa y. Intern Med. 2009;48(12):975-80. doi: 10.2169/internalmedicine.48.1902. Epub 2009 Jun 15. Intern Med. 2009. PMID: 19525583 Free article.
Twenty-four weeks of interferon alpha-2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1.
Fujiwara K, Yokosuka O, Komine F, Moriyama M, Kato N, Yoshida H, Tanaka N, Imazeki F, Shiratori Y, Arakawa Y, Omata M; Tokyo Hepatitis Network. Fujiwara K, et al. Among authors: arakawa y. Liver Int. 2006 Jun;26(5):520-8. doi: 10.1111/j.1478-3231.2006.01263.x. Liver Int. 2006. PMID: 16761995 Clinical Trial.
Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.
Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, Arakawa Y, Hashimoto E, Hirota K, Yoshida H, Ohashi Y, Omata M; Tokyo-Chiba Hepatitis Research Group. Shiratori Y, et al. Among authors: arakawa y. Ann Intern Med. 2005 Jan 18;142(2):105-14. doi: 10.7326/0003-4819-142-2-200501180-00009. Ann Intern Med. 2005. PMID: 15657158 Clinical Trial.
SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
Moriyama M, Mikuni M, Matsumura H, Nakamura H, Oshiro S, Aoki H, Shimizu T, Yamagami H, Shioda A, Kaneko M, Tanaka N, Arakawa Y. Moriyama M, et al. Among authors: arakawa y. Liver Int. 2005 Apr;25(2):226-35. doi: 10.1111/j.1478-3231.2005.01076.x. Liver Int. 2005. PMID: 15780043
1,322 results